India Tightens Regulations on IVF, Surrogacy Clinics: Kurnool DMHO Outlines New Requirements
Kurnool, India – In a move to ensure patient safety and ethical practise, Dr. P. Shanthi Kala, District Medical and Health Officer (DMHO) for Kurnool, has issued a comprehensive statement detailing the regulatory framework governing Assisted Reproductive technology (ART) clinics and surrogacy centers in the region. The proclamation underscores India’s position as a leading global destination for fertility treatments while emphasizing the importance of stringent oversight.
The Rise of ART in India & The Need for Regulation
Assisted Reproductive Technologies – including In Vitro Fertilisation (IVF), Intrauterine Insemination (IUI), and surrogacy – have revolutionized the treatment of infertility, offering hope to millions. India’s advanced medical infrastructure has attracted individuals from across the globe seeking these services. However, recognizing the potential for ethical concerns and the need to protect patients, the Indian government enacted the ART (Regulation) Act in 2021.
“The ART Act, 2021, establishes a robust legal and ethical framework for all ART procedures,” explains Dr. Shanthi Kala.”Our priority is to ensure transparency, maintain high quality standards, and safeguard the rights and well-being of individuals undergoing fertility treatment.”
Key Requirements for ART clinics & Banks
The DMHO’s statement outlines several critical requirements for all ART clinics and sperm/egg banks operating within the Kurnool district:
mandatory Registration: All clinics and banks must be registered with the National Registry through the ART National Portal. Tiered Clinic Categorization: Clinics are classified as either Level 1 or Level 2.
Level 1 Clinics: Offer basic services such as Intrauterine Insemination (IUI).
Level 2 Clinics: Provide advanced procedures including In vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI).
Strict Adherence to Standards: The Act mandates adherence to rigorous quality standards, comprehensive patient consent protocols, thorough screening procedures, and meticulous record-keeping.
Prohibition of Gamete & Embryo Sale: The sale of eggs, sperm, or embryos is strictly prohibited under the law.
* Integration with Public health: Emphasis is placed on integrating ART services into the broader public health system to enhance accessibility and oversight.
application & Inspection process
Fertility centers and surrogacy clinics are required to submit applications online via the ART National Portal, along with all necessary documentation, to the district medical and Health Office. A district-level inspection team will then thoroughly review each application.
registration certificates, valid for five years and renewable, will only be issued upon approval by the district committee. Dr. Shanthi Kala warned that regular inspections will be conducted to ensure ongoing compliance, and clinics found to be in violation of the regulations will face legal action.
Looking Ahead
This announcement signals a proactive approach to regulating the rapidly evolving field of assisted reproduction in India. By prioritizing ethical practices and patient safety, the Kurnool DMHO aims to maintain India’s reputation as a trusted and responsible destination for fertility treatments.
Keywords: ART, IVF, Surrogacy, India, Kurnool, ART Regulation Act 2021, Fertility Clinics, Infertility Treatment, Patient Safety, Medical Regulations, Healthcare, Reproductive Technology, National Registry, DMHO, Dr. P. Shanthi Kala.